The American Cancer Society updated colorectal cancer screening guidelines published in 2026 include recommendations for new molecular-based screening tests that received regulatory approval after the 2018 guidelines were released.1 Options for molecular-based screening include a multitarget stool RNA test (mt-sRNA), a next-generation multitarget stool DNA test (ng-mt-sDNA), and a blood-based cell-free DNA assay.